Treace Medical Concepts, Inc

TMCI Stock Forecast & Price Prediction

A data-driven outlook for TMCI built from live market pricing, discounted cash flow fair value, valuation multiples and ZCoreAI's Z-Score mean-reversion model. No opinions — only what the numbers currently imply.

$4.50+0.22% todayUSD · live quote

TMCI Price Outlook

$10.80
Model fair value per share (two-stage DCF, 10-year horizon)
Implied upside of 140.0% versus the current TMCI price of $4.50.
PV of projected FCF
$286.23M
PV of terminal value
$414.68M
Equity value
$700.91M
Growth assumption
7%

TMCI Historical Price Context

Two years of weekly closes for TMCI, with 52-week extremes and realized performance.

52-week high
$7.08
52-week low
$1.17
1-year performance
-29.6%
2-year performance
-22.4%

TMCI is trading 56% of the way up its 52-week range.

TMCI Valuation & Fundamentals

The multiples and growth rates that drive the TMCI forecast model.

Market cap
$292.01M
P/E (TTM)
Forward P/E
EPS (TTM)
$-0.93
Revenue growth
-4.2%
EPS growth
Net margin
-29.0%
Discount rate
9%
See the full TMCI DCF fair value breakdown →

TMCI Technical & Smart Money Context

Live Z-Score readings measure how far TMCI has stretched from its statistical regression mean on each timeframe. Extreme readings historically precede mean reversion.

1H
-1.32
Statistically neutral
4H
0.23
Statistically neutral
1D
1.26
Statistically neutral

How the TMCI Forecast Is Built

The TMCI price prediction combines three independent layers. First, a two-stage discounted cash flow model projects free cash flow ten years forward at 7% growth, applies a 2.5% perpetual terminal growth rate, and discounts every cash flow back to today at 9%. Second, current valuation multiples are compared against the growth and margin profile the company is actually delivering. Third, a Z-Score regression model measures how far price has stretched from its statistical mean on the 1H, 4H and daily timeframes.

Fair value is a valuation anchor, not a timing tool. A stock can stay above or below model fair value for long stretches, which is why the Z-Score layer exists — it identifies when TMCI is statistically stretched enough that mean reversion becomes probable. Nothing on this page is investment advice.

TMCI Stock Forecast FAQ

What is the TMCI stock forecast?

ZCoreAI derives the TMCI forecast from a DCF fair value of $10.80, current valuation multiples, and live Z-Score mean-reversion statistics. It is a model output based on today's data, not a guarantee of future prices.

How is the TMCI price prediction calculated?

Free cash flow is projected ten years forward, a Gordon-growth terminal value is capitalized, and both are discounted to present value. Net cash and debt are added to reach equity value, which is divided by shares outstanding to get a per-share number that is compared to the live TMCI price.

Is TMCI overvalued or undervalued right now?

On current inputs the model puts TMCI below fair value by 140.0%. Model inputs change as fundamentals update.

What does the TMCI Z-Score mean?

The Z-Score measures standard deviations from a regression mean. Below -3 signals an unusually stretched downside move, above +3 signals a stretched upside move, and readings in between are statistically neutral.

Can I trade TMCI signals live?

Yes. Open TMCI in the ZCoreAI terminal to see Smart Money structure, signal markers and fair-value overlays on the live chart, or review every recent alert on the signals page.

TMCI fair value

Full DCF intrinsic value breakdown for TMCI.

TMCI dividends

Payout history, yield and dividend growth for TMCI.

Live trading signals

Every recent Z-Score buy and sell alert across the market.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.